![TEVA PHARMACEUTICALS USA, INC: Teva Announces Updated Indication and Vial Presentation for GRANIX® (tbo-filgrastim) Injection in United States | American Pharmacy News TEVA PHARMACEUTICALS USA, INC: Teva Announces Updated Indication and Vial Presentation for GRANIX® (tbo-filgrastim) Injection in United States | American Pharmacy News](https://s3.amazonaws.com/jnswire/jns-media/59/3b/881504/teva.png)
TEVA PHARMACEUTICALS USA, INC: Teva Announces Updated Indication and Vial Presentation for GRANIX® (tbo-filgrastim) Injection in United States | American Pharmacy News
![Granix® Hematopoietic Agent TBO-Filgrastim, Preservative Free 480 mcg / 0.8 mL Subcutaneous Injection Prefilled Syringe 5 Syringes Granix® Hematopoietic Agent TBO-Filgrastim, Preservative Free 480 mcg / 0.8 mL Subcutaneous Injection Prefilled Syringe 5 Syringes](https://www.suprememed.com/pub/media/catalog/product/cache/64831c4317c6ec42652220923459f7ca/6/3/63459091236.jpg)
Granix® Hematopoietic Agent TBO-Filgrastim, Preservative Free 480 mcg / 0.8 mL Subcutaneous Injection Prefilled Syringe 5 Syringes
GRANIX (TBO-FILGRASTIM) INJECTION Trademark of TEVA Pharmaceutical Industries Limited Serial Number: 86040042 :: Trademarkia Trademarks
![These highlights do not include all the information needed to use GRANIX safely and effectively. See full prescribing information for GRANIX.GRANIX® (tbo-filgrastim) injection, for subcutaneous use Initial U.S. Approval: 2012 These highlights do not include all the information needed to use GRANIX safely and effectively. See full prescribing information for GRANIX.GRANIX® (tbo-filgrastim) injection, for subcutaneous use Initial U.S. Approval: 2012](https://dailymed.nlm.nih.gov/dailymed/image.cfm?name=image-54.jpg&id=467445)
These highlights do not include all the information needed to use GRANIX safely and effectively. See full prescribing information for GRANIX.GRANIX® (tbo-filgrastim) injection, for subcutaneous use Initial U.S. Approval: 2012
![Market Share by Filgrastim Brand (As a Percentage of Sales Before Rebates) | Download Scientific Diagram Market Share by Filgrastim Brand (As a Percentage of Sales Before Rebates) | Download Scientific Diagram](https://www.researchgate.net/profile/Jakub-Hlavka/publication/326044861/figure/fig2/AS:642582132559873@1530214927695/Market-Share-by-Filgrastim-Brand-As-a-Percentage-of-Sales-Before-Rebates_Q640.jpg)
Market Share by Filgrastim Brand (As a Percentage of Sales Before Rebates) | Download Scientific Diagram
![These highlights do not include all the information needed to use GRANIX safely and effectively. See full prescribing information for GRANIX.GRANIX® (tbo-filgrastim) injection, for subcutaneous use Initial U.S. Approval: 2012 These highlights do not include all the information needed to use GRANIX safely and effectively. See full prescribing information for GRANIX.GRANIX® (tbo-filgrastim) injection, for subcutaneous use Initial U.S. Approval: 2012](https://dailymed.nlm.nih.gov/dailymed/image.cfm?name=image-53.jpg&id=467445)